Effect of Guided Imagery on Patients With Chronic Pain Related to Spinal Cord Injury
Chronic pain after spinal cord injury in or below the level of injury is a common problem and can be severe.
The purpose of our study is to investigate the effect of pleasant guided imagery on spinal cord injured patients with chronic pain in or below the level of injury.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Participant)
Primary Purpose: Treatment
|Official Title:||Effect of Positive Guided Imagery on Patients With in or Below-level Chronic Pain Related to Spinal Cord Injury|
- Pain intensity [ Time Frame: four weeks ]as measured by a numerical rating scale (daily) and Brief pain questionnaire (BPI) (baseline and after 4 weeks)
- BDI, BAI and SF36 [ Time Frame: pre and postintervention ]
|Study Start Date:||October 2008|
|Study Completion Date:||March 2009|
|Primary Completion Date:||March 2009 (Final data collection date for primary outcome measure)|
Experimental: guided imagery
Behavioral: Pleasant guided imagery
CD with pleasant guided imagery
Active Comparator: pain diary
Behavioral: Pain diary
Filling out a pain diary
The study is a controlled simple blind randomized prospective study. Subjects who live in Trøndelag ( Norway) and who have a traumatic or non traumatic spinal cord injury with chronic pain in or below the level of injury will be included in the study.
Assessments: Pain will be measured with NRS(numeric pain rating scale) and BPIQ (Brief pain intervention questionnaire), anxiety and depression with BDI and BAI (Beck`s depression and anxiety inventory) and quality of live with SF36 health survey.
The subjects will be randomized in a treatment and control group. One group will use daily for four weeks a CD with a pleasant guided imagery, the other group will write a short pain diary.
The NRS will be registered daily and the other assessments before and after the interventions.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00678548
|Principal Investigator:||Gunnar Leivseth, Professor MD||Norwegian University of Science and Technology|